Concord medical purchases additional proton therapy system for it's shanghai concord cancer center

Beijing, sept. 10, 2021 /prnewswire/ -- concord medical services holdings limited ("concord medical" or the "company") (nyse: ccm), a healthcare provider specialized in cancer treatment, research, education, and prevention by establishing proton centers and specialty cancer hospitals and operating an extensive network of radiotherapy and diagnostic imaging centers in china, today announced that shanghai concord cancer center ("sccc", or the "planned hospital"), a business subsidiary of an important operating platform of the company, meizhong jiahe medical science & technology development group co., ltd.
CCM Ratings Summary
CCM Quant Ranking